TBPH Change in Working Capital
Theravance Biopharma Inc · Change in Working Capital
TBPH Change in Working Capital
Latest reported$242.87Mperiod ending
TBPH Change in Working Capital (-$1.85M → $242.87M)
Annual change in working capital
High-resolution chart · PNG
TBPH change in working capital history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| 120,471,000 | |
| 20,355,000 | |
| -8,340,000 | |
| 42,350,000 | |
| -39,549,000 | |
| -37,777,000 | |
| -45,400,000 | |
| 59,429,000 | |
| 22,431,000 | |
| 46,928,000 | |
| -37,783,000 | |
| 12,770,000 | |
| 10,176,000 | |
| -134,302,000 | |
| -1,845,000 |